Prevalence of Asthma and Allergies among children in UAE - ISAAC-UAE
Study identifier:D2287R00142
ClinicalTrials.gov identifier:NCT03878680
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prevalence of Asthma and Allergies among children in UAE-A cross-sectional study
Medical condition
asthma
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3737
Study type
Observational
Age
N/A
Date
Study Start Date: 30 Apr 2019
Primary Completion Date: 26 Jun 2019
Study Completion Date: 26 Jun 2019
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jul 2020 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 13-14 years age group Children with age 13-14 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE. | Other: Study questionnaires Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires: 1. Core questionnaire on wheezing. 2. Core questionnaire on rhinitis. 3. Core questionnaire on atopic dermatitis. |
| 6-7 years age goup Children with age 6-7 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE. | Other: Study questionnaires Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires: 1. Core questionnaire on wheezing. 2. Core questionnaire on rhinitis. 3. Core questionnaire on atopic dermatitis. |
